C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2006
11/21/2006	US7138375 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs
11/21/2006	US7138374 Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, asparate 101 or leucine 137
11/21/2006	US7138371 Remodeling and glycoconjugation of peptides
11/21/2006	US7138370 Anticancer agents; skin disorders; antiinflamamtory agents; antiarthritic agents
11/21/2006	US7138369 Compounds and methods for modulating apoptosis
11/21/2006	US7138277 Genes encoding plant transcription factors
11/21/2006	US7138276 Differentiation-suppressive polypeptide serrate-2 and methods of use
11/21/2006	US7138273 Screening for genes which trigger hypersensitive response in tobacco plants in presence of ubiquitous Phytophthora infestans elicitor; horticulture
11/21/2006	US7138255 Method of isolation and self-assembly of small protein particles from blood and other biological materials
11/21/2006	US7138253 Nucleic acid encoding a peptide that binds streptavidin with a dissociation constant less than 10 mu M and that is not disulfide bonded or cyclized; may be expressed as part of fusion proteins to facilitate the detection, quantitation, and purification of proteins of interest.
11/21/2006	US7138252 For prevention/treatment of allergies/cancer/drug addiction/poisoning
11/21/2006	US7138251 Polynucleic acid molecule encoding receptors for glial cell line-derived neurotrophic factor
11/21/2006	US7138248 Method of inhibiting inward rectifier, G-protein activated, mammalian, potassium channels and uses thereof
11/21/2006	US7138247 An antibody directed against particular amino acid regions of Hsp70B' and its preparation by administering a peptide corresponding, or antigenically equivalent, to those regions; detection of the stress-inducible Hsp70B' protein
11/21/2006	US7138244 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
11/21/2006	US7138243 NTB-A, a surface molecule involved in natural killer cells activity
11/21/2006	US7138242 Replication primer sequences for identifying ligand-binding domains for detection of neuron odorants, toxic odors and which can be used to manipulate odor response in animals
11/21/2006	US7138240 Detection of protein receptor activity in a cell; detecting translocation of a detectable molecule from the cytosol to the membrane edge of the cell; translocation indicates receptor activity
11/21/2006	US7138236 Interactions of ATM, ATR or DAN-PK with p53
11/21/2006	US7138235 Nucleic acid molecules comprising the promoter for PCA3, and uses thereof
11/21/2006	US7138234 Gene involved in CADASIL, method of diagnosis and therapeutic application
11/21/2006	US7138231 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
11/21/2006	US7138150 Expressing a nucleic acid encoding protein selected from lactoferrin protein and lysozyme protein in a monocot seed; isolating protein from the seed, combining with carrier diluent to provide formulation for oral administration
11/21/2006	US7138127 Clostridial toxin derivatives and methods for treating pain
11/21/2006	US7138126 Modifying wild strain of enteroinvasive Shigella; cannot spread within infected cells and from infected to uninfected cells of the host; vaccines; deactivation by inserting transposon into gene; mutagenizing; genetically engineered by allelic exchange
11/21/2006	US7138125 Polypeptide for prevention, therapy of bacteria infections; gramnegative bacteria; therapy for reduced lactation in animals
11/21/2006	US7138124 Lipopolysaccharides; forming antibodies; isolation exterior membrane polypeptide
11/21/2006	US7138119 Compositions and methods for inhibition of HIV-1 infection
11/21/2006	US7138118 Methods of treating rheumatoid arthritis with anti-TNF antibodies
11/21/2006	US7138112 Plasmid maintenance system for antigen delivery
11/21/2006	CA2478621C Botulinum toxin pharmaceutical compositions
11/21/2006	CA2433386C Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein staau_r9
11/21/2006	CA2078003C Tumor killing effects of enterotoxins and related compounds
11/21/2006	CA2076793C Methods and reagents for hepatitis c detection
11/21/2006	CA1341515C Hormone receptor compositions and methods
11/17/2006	CA2549902A1 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
11/16/2006	WO2006122327A2 Milk fat globule epidermal growth factor-factor viii and sepsis
11/16/2006	WO2006122205A2 Conus californicus neurotoxins
11/16/2006	WO2006122079A1 Il-31 monoclonal antibodies and methods of use
11/16/2006	WO2006122060A1 Compositions and uses of secreted polypeptide, zsig98
11/16/2006	WO2006122049A2 Pna probes for detecting mollicutes
11/16/2006	WO2006121926A2 Neural regeneration peptides and methods for their use
11/16/2006	WO2006121886A1 Automated compound screening using gel-permeation matrix and pin-based sample transfer
11/16/2006	WO2006121810A2 Trimeric ox40-immunoglobulin fusion protein and methods of use
11/16/2006	WO2006121700A2 Hydratable keratin compositions
11/16/2006	WO2006121569A2 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
11/16/2006	WO2006121454A2 Use of mapc or progeny therefrom to populate lymphohematopoietic tissues
11/16/2006	WO2006121240A1 Acute leukemia and lymphoblastic lymphoma-specific cd43 epitope and use thereof
11/16/2006	WO2006120678A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
11/16/2006	WO2006120580A2 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides
11/16/2006	WO2006120579A2 Methods for detecting virulent plasmodium, for evaluating plasmodium virulence, and for screening new drugs employing the 3'utr of plasmodium sub2 and the plasmodium sub2 serine protease
11/16/2006	WO2006120473A2 Mhc class i and ii peptide antigens derived from tumour antigen 5t4
11/16/2006	WO2006120455A2 Ovalbumin promoter constructs for retroviral vectors
11/16/2006	WO2006120429A1 Affinity adsobents for fibrinogen
11/16/2006	WO2006120427A1 Affinity adsorbents for factor viii and von willebrand's factor
11/16/2006	WO2006120034A1 Vaccine composition
11/16/2006	WO2006120030A1 Erythropoietin variants
11/16/2006	WO2006119983A2 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
11/16/2006	WO2006119965A2 Growth factor mutants with altered biological attributes
11/16/2006	WO2006119767A2 Neuritogenic peptides
11/16/2006	WO2006119644A1 New purification method of lactoferrin
11/16/2006	WO2006119542A1 A crystal structure and uses thereof
11/16/2006	WO2006088955A3 Methods of treating diseases which are mediated by cutaneous lymphocyte antigen positive cells
11/16/2006	WO2006082110A3 Salt taste receptor and its use in an assay for salt taste
11/16/2006	WO2006071691A3 Rnai inhibition of serum amyloid a for treatment of glaucoma
11/16/2006	WO2006068663A3 Vaccine compositions for treating coronavirus infection
11/16/2006	WO2006056590A3 Plants having increased yield and a method for making the same
11/16/2006	WO2005110465A3 Oral formulations comprising bone morphogenetic proteins for treating metabolic bone diseases
11/16/2006	WO2005104834A3 Pain-associated gene pnpg5
11/16/2006	WO2005082020A8 Flavivirus vaccines
11/16/2006	WO2005023981A3 Libraries of chimeric cellulose binding proteins and methods of use thereof
11/16/2006	WO2003087129A3 Immunogenic peptides, and method of identifying same
11/16/2006	WO2001057190A3 Novel nucleic acids and polypeptides
11/16/2006	US20060260013 Root-specific phosphate transporter promoters
11/16/2006	US20060260008 vectors, transformed host cells that contain nucleic acid segments that encode the disclosed delta -endotoxin polypeptides; Bacillus thuringiensis cell
11/16/2006	US20060259996 Structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like (tissue differentiation factor) receptors; methods of detecting, preventing, and treating TDF-associated disorders
11/16/2006	US20060259993 Amidases, nucleic acids encoding them and methods for making and using them
11/16/2006	US20060259988 Use of dg931 protein for treating diabetes, obesity and metabolic syndrome
11/16/2006	US20060259987 Variants of antithrombin III
11/16/2006	US20060259247 Apparatus and method for automated protein design
11/16/2006	US20060258851 Hybird molecules having factor VII/VIIa activity
11/16/2006	US20060258850 Method for preparing human serum albumin through heat-treatment in the presence of divalent cation
11/16/2006	US20060258849 Nucleic acids and proteins from streptococcus groups A & B
11/16/2006	US20060258848 Human antipneumococcal antibodies from non-human animals
11/16/2006	US20060258847 Exposing a test inhibitor to botulinum toxin light chain;evaluating the biological activity; inhibitors target holotoxin translocation and light chain metalloprotease activity of the botulinum toxin
11/16/2006	US20060258846 Crystal structure of SNAP-25 in complex with botulinum neurotoxin and uses thereof
11/16/2006	US20060258845 Novel purified polypeptides from Staphylococcus aureus
11/16/2006	US20060258844 Algae fluorescence protein dry powder structure and manufacturing method thereof
11/16/2006	US20060258843 altered biological persistence; modified botulinum light chain containing a tyrosine phosphorylation site located within the first 10 amino acids of the N-terminal of the modified light chain; for therapy of neuromuscular disorders, autonomic nervous system disorders and pain
11/16/2006	US20060258842 Fully humanized monoclonal antibodies that neutralize Bacillus anthracis lethal toxin; vaccines
11/16/2006	US20060258841 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
11/16/2006	US20060258840 Peroxisome proliferator-activated receptor
11/16/2006	US20060258839 Cardiovascular disorders; antiinflammatory agents; resemble a G amphipathic helix of apolipoprotein J; phospholipids
11/16/2006	US20060258838 Preparation of somatostatin peptides
11/16/2006	US20060258702 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258660 Stabilization of hypoxia inducible factor (HIF) alpha
11/16/2006	US20060258611 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference
11/16/2006	US20060258596 Antimicrobial agents
11/16/2006	US20060258595 Apoptosis of rectum and prostate gland cancer
11/16/2006	US20060258594 Antibodies to the HIV-1 Tat protein, which bind specifically to a specific epitope found in different HIV-1 strains and subtypes; for use in passive therapy

1 ... 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 ... 2916